Friday, May 13, 2016

BRIEF-Tobira Therapeutics announces publication of phase 1 study results showing Cenicriviroc safety in Cirrhotic patients

* Tobira therapeutics announces publication of phase 1 study

results showing cenicriviroc safety in cirrhotic patients

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)